GYNECOLOGIC ONCOLOGY GROUP

描述（由申请人提供）：本申请是妇科肿瘤组（GOG）CCOP研究基地。GOG是一个非营利性组织，致力于促进妇科恶性肿瘤领域的临床、转化和基础科研的卓越发展。作为全球领先的妇科癌症预防和治疗临床试验组织，GOG制定了一个积极和富有成效的癌症和预防控制计划（CPC）。CPC委员会由GOG于1995年发起，现已发展到46名成员，并于2005年成立了执行委员会，以更好地指导IIb和III期临床试验以及观察性和临床转化研究的开发，激活和完成。CPC执行委员会成员包括CPC委员会联合主席、NCI-Division癌症预防代表（Minasian和Kelaghan博士）、预防成员（Byron和Garcia博士）、CCOP成员（Rodriguez和Method博士）、实验医学和医疗保健结果研究委员会成员以及GOG统计和数据中心和行政办公室的代表。中国共产党执行委员会每年举行六次电话会议，监督中国共产党疾病现场和纪律小组委员会的工作。GOG附属网络主要由社区机构组成，在一个正式成员机构的监督下工作。此外，GOG还是31个CCOP和155个CCOP组成部分的研究基地，这些组成部分在许多非常有限的领域提供国家临床试验。CCOP领导人对方法领导GOG-0224的研究方向有直接的投入。CCOPs为患者提供了访问机会，而患者反过来又可以获得高质量的临床试验。除了为CCOP社区提供强大的癌症预防和治疗研究环境外，GOG还在其每次会议上提供关于高质量妇科和癌前管理科学基础的前沿深入研讨会和研讨会。

DESCRIPTION (provided by applicant): This application is for the Gynecologic Oncology Group (GOG) CCOP Research Base. The GOG is a nonprofit organization promoting excellence in clinical, translational and basic scientific research in the field of gynecologic malignancies. As the premier world-wide clinical trial group in the prevention and treatment of gynecologic cancers, the GOG has developed an active and productive cancer and prevention control program (CPC). The CPC committee was initiated by the GOG in 1995 and has grown to 46 members with an Executive committee developed in 2005 to better guide the development, activation and completion of phase lib and III clinical trials and observational and clinical translational studies. The CPC Executive Committee membership includes the CPC Committee Co-Chairs, ex-officio NCI-Division of Cancer Prevention representatives (Drs. Minasian and Kelaghan), prevention members (Drs. Byron and Garcia), CCOP members (Drs, Rodriguez and Method), members of the Committees on Experimental Medicine and Healthcare Outcome Research and representatives of the GOG Statistical and Data Center and Administrative Office. Meeting by conference call six times yearly, the CPC Executive Committee oversees the work of the CPC disease-site and discipline subcommittees. The GOG affiliate network is made up of primarily community based institutions working under the supervision of a full member institution. In addition, the GOG serves as a research base for 31 CCOPs and 155 CCOP components that provide national clinical trials in many areas of very limited access. The CCOP leaders have direct input to the research directions of Method leads GOG-0224. The CCOPs provide access to patients, and patients in turn are provided access to high quality clinical trial. In addition to providing a strong environment of cancer prevention and treatment research to the CCOP community, the GOG provides, at each of its meetings, cutting edge, in depth workshops and seminars concerning the scientific underpinning for high quality gynecologic and pre cancer management.